- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04047277
Cognitive Behavioral Therapy for Nightmares in Children (CBT-NC)
November 9, 2022 updated by: University of Oklahoma
Clinical Outcomes of Cognitive Behavioral Therapy for Nightmares in Children
Up to 50% of children experience nightmares annually.
Nightmares interfere with sleep quality and quantity resulting in sleep deficiency, and are associated with negative mental health consequences.
Previous research has shown efficacy of manualized CBT treatment for reducing trauma related nightmares in adults, and preliminary evidence has shown efficacy in children.
This study is the first randomized clinical trial to evaluate the effectiveness of the treatment for idiopathic, as well as trauma related nightmares in children.
The treatment in a manualized CBT protocol (5 sessions) that teaches sleep hygiene, relaxation strategies, and addresses nightmares therapeutically through exposure and rescripting.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
24
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Oklahoma
-
Tulsa, Oklahoma, United States, 74135
- University of Oklahoma School of Community Medicine
-
Tulsa, Oklahoma, United States, 74104
- University of Tulsa
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 year to 13 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Children must have a history of nightmares occurring approximately once or more per week over a minimum of one month.
- Children must have verbal comprehension of at least age 5 (determined by PPVT), and be fluent in English.
- If taking psychotropic medications, must be stable for one month.
- Children must have a parent or legal guardian who is able to participate in treatment assignments and be able to read and speak English.
Exclusion Criteria:
- Under age 5 or over age 17.
- No nightmares (or less than averaging one per week)
- Apparent psychosis
- Pervasive developmental disorder or mental retardation
- Not able to read and speak English.
- Sleep apnea
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Waitlist Control
Waitlist control group will complete pre and post assessments at beginning and end of wait period.
|
|
|
Experimental: Treatment Right-Away
Cognitive Behavioral Therapy using exposure, relaxztion, and rescripting - Child utilizes behavioral and cognitive therapy techniques of exposure therapy and cognitive restructuring.
|
The manualized CBT protocol is five sessions that teach sleep hygiene, relaxation strategies, and addresses nightmares therapeutically through exposure and rescripting.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change on the Child Adolescent Trauma Screen (CATS) - Child Version
Time Frame: Participants will be assessed at Baseline (Week 0) through study completion, an average of 6 months.
|
The CATS screens for child trauma history and PTSD symptoms in youth ages 7-17; 15 YES/NO questions; 1 open-ended question
|
Participants will be assessed at Baseline (Week 0) through study completion, an average of 6 months.
|
|
Change on the Trauma Related Nightmare Survey (TRNS-C) - Child Version
Time Frame: Participants will be assessed at Baseline (Week 0) through study completion, an average of 6 months.
|
The TRNS-C is a 14 item self report measure that assesses current sleep quality, frequency, severity, and duration of nightmares, as well as cognitions, emotions, and behaviors related to nightmares in children.
|
Participants will be assessed at Baseline (Week 0) through study completion, an average of 6 months.
|
|
Change on the Nightmare Distress Questionnaire (NDQ)
Time Frame: Participants will be assessed at Baseline (Week 0) through study completion, an average of 6 months.
|
The NDQ is a 13 item self report measure of nightmare related distress.
Higher scores are significantly related to interest in therapy for nightmares.
|
Participants will be assessed at Baseline (Week 0) through study completion, an average of 6 months.
|
|
Change on the Nightmare Locus of Control (NLOC)
Time Frame: Participants will be assessed at Baseline (Week 0) through study completion, an average of 6 months.
|
The N-LOC is an 6 item self report.
This scale is collected as a child self report, and a caregiver report regarding child.
|
Participants will be assessed at Baseline (Week 0) through study completion, an average of 6 months.
|
|
Change on the Pittsburgh Sleep Quality Index - Modified (PSQI) - Child Version
Time Frame: Participants will be assessed at Baseline (Week 0) through study completion, an average of 6 months.
|
The PSQI-M is a 10 item (with 2 items containing 23 sub items) self report measure of sleep quality and disturbance.
It queries sleep quality and disturbances over the last month.
|
Participants will be assessed at Baseline (Week 0) through study completion, an average of 6 months.
|
|
Change on the Children's Report of Sleep Patterns (CRSP)
Time Frame: Participants will be assessed at Baseline (Week 0) through study completion, an average of 6 months.
|
The CRSP is a 62 item self report measure of children's sleep patterns, sleep hygiene, and sleep disturbances for children eight to 12 years of age
|
Participants will be assessed at Baseline (Week 0) through study completion, an average of 6 months.
|
|
Change on the Sleep Locus of Control (SLOC)
Time Frame: Participants will be assessed at Baseline (Week 0) through study completion, an average of 6 months.
|
The SLOC is an 6 item self report measure perceived contingencies between sleep behavior and events.
This scale is collected as a child self report, and a caregiver report regarding child.
|
Participants will be assessed at Baseline (Week 0) through study completion, an average of 6 months.
|
|
Change on the Epworth Sleepiness Scale (ESS)
Time Frame: Participants will be assessed at Baseline (Week 0) through study completion, an average of 6 months.
|
The ESS is an 8 item self report.
The test is a list of eight situations in which one rates his/her tendency to become sleepy on a scale of 0, no chance of dozing, to 3, high chance of dozing.
When the test is finished, response values are added up.
The total score is based on a scale of 0 to 24.
The scale estimates whether one is experiencing excessive sleepiness that possibly requires medical attention.
|
Participants will be assessed at Baseline (Week 0) through study completion, an average of 6 months.
|
|
Change in reports on Sleep Journal
Time Frame: Participants complete this assessment at Pre-treatment (for 1 week), daily during the treatment phase, at Post treatment (for 1 week), at 3 month follow-up (for 1 week), and at 6 month follow-up (for 1 week).
|
6 question self report that patient assesses daily from home.
|
Participants complete this assessment at Pre-treatment (for 1 week), daily during the treatment phase, at Post treatment (for 1 week), at 3 month follow-up (for 1 week), and at 6 month follow-up (for 1 week).
|
|
Change on the Child Adolescent Trauma Screen (CATS) - Caregiver Report regarding child
Time Frame: Participants will be assessed at Baseline (Week 0) through study completion, an average of 6 months.
|
The CATS screens for child trauma history and PTSD symptoms (information obtained from the caregiver, about the child).
|
Participants will be assessed at Baseline (Week 0) through study completion, an average of 6 months.
|
|
Change on the Children's Sleep Habits - Caregiver Report regarding child
Time Frame: Participants will be assessed at Baseline (Week 0) through study completion, an average of 6 months.
|
To examine sleep habits and possible difficulties with sleep in preschool and school-aged children
|
Participants will be assessed at Baseline (Week 0) through study completion, an average of 6 months.
|
|
Adverse Childhood Experiences for CHILD - Caregiver Report regarding child
Time Frame: approximately 3 years.
|
Assesses adverse experiences from infancy through early childhood
|
approximately 3 years.
|
|
Change on the Sleep Disturbances Scale for Children - Caregiver Report regarding child
Time Frame: Participants will be assessed at Baseline (Week 0) through study completion, an average of 6 months.
|
SDSC is a 26-item inventory rated on a 5 point Likert-type scale.
The instrument's purpose is to categorize sleep disorders in children
|
Participants will be assessed at Baseline (Week 0) through study completion, an average of 6 months.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change on the Parental Stress Scale
Time Frame: Participants will be assessed at Baseline (Week 0) through study completion, an average of 6 months.
|
18 item self report scale used for the assessment of parental stress for both mothers and fathers and for parents of children with and without clinical problems.
• 5 - Point scale; strongly disagree, disagree, undecided, agree, strongly agree.
A low score signifies a low level of stress, and a high score to signifies a high level of stress.
|
Participants will be assessed at Baseline (Week 0) through study completion, an average of 6 months.
|
|
Adverse Childhood Experiences for SELF - Caregiver Report regarding self
Time Frame: approximately 3 years.
|
Assesses adverse experiences from infancy through early childhood
|
approximately 3 years.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Lisa M Cromer, PhD, University of Tulsa
- Principal Investigator: Tara R Buck, MD, University of Oklahoma School of Community Medicine
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 22, 2019
Primary Completion (Actual)
October 30, 2020
Study Completion (Actual)
October 30, 2020
Study Registration Dates
First Submitted
June 5, 2019
First Submitted That Met QC Criteria
August 5, 2019
First Posted (Actual)
August 6, 2019
Study Record Updates
Last Update Posted (Actual)
November 15, 2022
Last Update Submitted That Met QC Criteria
November 9, 2022
Last Verified
November 1, 2022
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- IRB9653
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Nightmare
-
Tel Aviv UniversityActive, not recruiting
-
Uniformed Services University of the Health SciencesUnited States Naval Medical Center, San Diego; Walter Reed National Military...Completed
-
Goethe UniversityCompleted
-
NightWareMinneapolis Veterans Affairs Medical Center; Walter Reed National Military... and other collaboratorsCompletedStress Disorders, Post-Traumatic | Combat Disorders | Nightmare | Nightmares, REM-Sleep Type | Ptsd | Nightmare Disorder With Associated Non-Sleep DisorderUnited States
-
NightWareMinneapolis Veterans Affairs Medical CenterCompletedStress Disorders, Post-Traumatic | Combat Disorders | Nightmare | Nightmares, REM-Sleep Type | Ptsd | Nightmare Disorder With Associated Non-Sleep DisorderUnited States
-
University of OklahomaUniversity of TulsaCompletedSuicidal Ideation | Children, Only | NightmareUnited States
-
University of UtahRecruitingREM Sleep Behavior Disorder | Nightmare | Nightmare Disorder With Associated Other Sleep DisorderUnited States
-
University of OklahomaUniversity of TulsaCompleted
Clinical Trials on Cognitive Behavioral Therapy
-
Eleos HealthMissouri Department of Mental HealthCompletedMood Disorders | Anxiety DisordersUnited States
-
Regionsenter for barn og unges psykiske helseThe Research Council of NorwayCompletedGeneralized Anxiety Disorder | Social Phobia | Separation Anxiety DisorderNorway
-
Claremont McKenna CollegeUniversity of California, Los AngelesCompleted
-
Aleksandra StojanovicRecruitingAnxiety Disorders | Depression - Major Depressive DisorderSerbia
-
University of RochesterNational Institute of Nursing Research (NINR)CompletedDepression | Sleep | Stress Disorders, Post-TraumaticUnited States
-
University of South FloridaObsessive Compulsive FoundationCompletedObsessive Compulsive Disorder | Stepped Care Cognitive Behavioral TherapyUnited States
-
University of North Carolina, Chapel HillNational Institute of Mental Health (NIMH)Completed
-
Vanderbilt UniversityNational Institute of Mental Health (NIMH)RecruitingDepressionUnited States
-
Ibn Haldun UniversityNot yet recruiting
-
University of PittsburghWithdrawnPsychosis | Prodromal Symptoms | Prodromal Stage | Prodromal StatesUnited States